Monitoring of electromagnetic (EM) radiation from mobile telecommunication systems in living environment, analysis of molecular mechanisms and biomarker defects in the case of chronic exposure, with development of risk estimation models and methods for p

Link to this page

info:eu-repo/grantAgreement/MESTD/Integrated and Interdisciplinary Research (IIR or III)/43012/RS//

Monitoring of electromagnetic (EM) radiation from mobile telecommunication systems in living environment, analysis of molecular mechanisms and biomarker defects in the case of chronic exposure, with development of risk estimation models and methods for p (en)
Мониторинг електромагнетних зрачења мобилних телекомуникационих система у животној средини, анализа молекуларних механизама и биомаркера оштећења код хроничне изложености са развојем модела за процену ризика и метода за заштиту (sr)
Monitoring elektromagnetnih zračenja mobilnih telekomunikacionih sistema u životnoj sredini, analiza molekularnih mehanizama i biomarkera oštećenja kod hronične izloženosti sa razvojem modela za procenu rizika i metoda za zaštitu (sr_RS)
Authors

Publications

T4 Glottic carcinoma: oncological results and survival rate

Jancić, Slavisa; Zivić, Miško; Radovanović, Zoran; Miličić, Biljana; Đinđić, Nataša; Đinđić, Boris; Jančić, Snežana

(Drunpp-Sarajevo, Sarajevo, 2011)

TY  - JOUR
AU  - Jancić, Slavisa
AU  - Zivić, Miško
AU  - Radovanović, Zoran
AU  - Miličić, Biljana
AU  - Đinđić, Nataša
AU  - Đinđić, Boris
AU  - Jančić, Snežana
PY  - 2011
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1611
AB  - Objectives/Background: The best course of action in the case of T4 glottic carcinoma is chosen for each individual case. The aim of this study was to evaluate the potential prognostic factors and influence of postoperative and radical radiotherapy on the survival rate of patients suffering from T4 glottic carcinoma and to analyze the most appropriate conservative treatment for these patients. Methods: Study Design: A retrospective study (1995-2000) enrolled 63 patients with squamo-cellular glottic cancer in T4N1M0 stage, monitored for 5 years, divided into two groups: 30 postoperatively irradiated patients and 33 radically irradiated patients. Analysed variables were: age, sex, total therapeutical dose, number of fractions, dose per fraction and type of radiotherapeutical treatment. Standard therapeutical fractionation regimens were used, with daily sessions of 2-3 Gy, five times a week. Radiotherapy consisted of mega-voltage 10 MEV X-ray therapy. Log Rank test, Kaplan-Meier survival study, t-test, Pearson X2 - test and Cox regression were used in order to select the factors with independent effect. Results: Multivariate analysis demonstrated that none of the predictors, not even the type of radiation therapy, were statistically significant, with independent influence on survival. Conclusion: There is no significant difference in survival of patients with T4 glottic carcinoma among postoperatively and radically irradiated patients. Our results imply that the optimal radiotherapeutic modality for these patients is a total therapeutical dose no less than 65 Gy and daily fractionation with dose no less than 2,51Gy.
PB  - Drunpp-Sarajevo, Sarajevo
T2  - HealthMED
T1  - T4 Glottic carcinoma: oncological results and survival rate
VL  - 5
IS  - 6
SP  - 1737
EP  - 1743
UR  - https://hdl.handle.net/21.15107/rcub_smile_1611
ER  - 
@article{
author = "Jancić, Slavisa and Zivić, Miško and Radovanović, Zoran and Miličić, Biljana and Đinđić, Nataša and Đinđić, Boris and Jančić, Snežana",
year = "2011",
abstract = "Objectives/Background: The best course of action in the case of T4 glottic carcinoma is chosen for each individual case. The aim of this study was to evaluate the potential prognostic factors and influence of postoperative and radical radiotherapy on the survival rate of patients suffering from T4 glottic carcinoma and to analyze the most appropriate conservative treatment for these patients. Methods: Study Design: A retrospective study (1995-2000) enrolled 63 patients with squamo-cellular glottic cancer in T4N1M0 stage, monitored for 5 years, divided into two groups: 30 postoperatively irradiated patients and 33 radically irradiated patients. Analysed variables were: age, sex, total therapeutical dose, number of fractions, dose per fraction and type of radiotherapeutical treatment. Standard therapeutical fractionation regimens were used, with daily sessions of 2-3 Gy, five times a week. Radiotherapy consisted of mega-voltage 10 MEV X-ray therapy. Log Rank test, Kaplan-Meier survival study, t-test, Pearson X2 - test and Cox regression were used in order to select the factors with independent effect. Results: Multivariate analysis demonstrated that none of the predictors, not even the type of radiation therapy, were statistically significant, with independent influence on survival. Conclusion: There is no significant difference in survival of patients with T4 glottic carcinoma among postoperatively and radically irradiated patients. Our results imply that the optimal radiotherapeutic modality for these patients is a total therapeutical dose no less than 65 Gy and daily fractionation with dose no less than 2,51Gy.",
publisher = "Drunpp-Sarajevo, Sarajevo",
journal = "HealthMED",
title = "T4 Glottic carcinoma: oncological results and survival rate",
volume = "5",
number = "6",
pages = "1737-1743",
url = "https://hdl.handle.net/21.15107/rcub_smile_1611"
}
Jancić, S., Zivić, M., Radovanović, Z., Miličić, B., Đinđić, N., Đinđić, B.,& Jančić, S.. (2011). T4 Glottic carcinoma: oncological results and survival rate. in HealthMED
Drunpp-Sarajevo, Sarajevo., 5(6), 1737-1743.
https://hdl.handle.net/21.15107/rcub_smile_1611
Jancić S, Zivić M, Radovanović Z, Miličić B, Đinđić N, Đinđić B, Jančić S. T4 Glottic carcinoma: oncological results and survival rate. in HealthMED. 2011;5(6):1737-1743.
https://hdl.handle.net/21.15107/rcub_smile_1611 .
Jancić, Slavisa, Zivić, Miško, Radovanović, Zoran, Miličić, Biljana, Đinđić, Nataša, Đinđić, Boris, Jančić, Snežana, "T4 Glottic carcinoma: oncological results and survival rate" in HealthMED, 5, no. 6 (2011):1737-1743,
https://hdl.handle.net/21.15107/rcub_smile_1611 .